John Frederick Cooper

Mr. John Frederick Cooper


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
AVAlessandra Esperanza Vaccaro
Alessandra Esperanza Vaccaro
JCJohn Frederick Cooper
John Frederick Cooper
JVJesus Augusto Vazquez-Rodriguez
Jesus Augusto Vazquez-Rodriguez
Hamid BadaliHamid Badali
Hamid Badali
RKRyan Kean
Ryan Kean
Jose Lopez-RibotJose Lopez-Ribot
Jose Lopez-Ribot
Candidozyma auris (formerly Candida auris) is an emerging multidrug-resistant pathogenic fungus with an increased ability to cause outbreaks in healthcare facilities, leading to poor patient outcomes. Since its initial discovery in 2009, C. auris has spread rapidly across continents and is now classified by both the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) as a critical-priority pathogen. This review summarizes current knowledge on the origin, taxonomy, microbiology, and virulence mechanisms of C. auris, emphasizing its thermotolerance, osmotolerance, and biofilm-forming capacity on biotic and abiotic surfaces, as well as aspects related to its antifungal drug resistance and management. These features, together with its genomic plasticity, contribute to persistence, transmission, and drug resistance. Emerging evidence also supports a potential link between climate change and C. auris evolution, highlighting environmental adaptation as a driver of pathogenicity. Combating C. auris will require multidisciplinary efforts to mitigate its expanding global impact.

14 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AVAlessandra Esperanza Vaccaro
Alessandra Esperanza Vaccaro
JCJohn Frederick Cooper
John Frederick Cooper
JVJesus Augusto Vazquez-Rodriguez
Jesus Augusto Vazquez-Rodriguez
Hamid BadaliHamid Badali
Hamid Badali
RKRyan Kean
Ryan Kean
Jose Lopez-RibotJose Lopez-Ribot
Jose Lopez-Ribot
Candidozyma auris (formerly Candida auris) is an emerging multidrug-resistant pathogenic fungus with an increased ability to cause outbreaks in health care facilities leading to poor patient outcomes. Since its initial discovery in 2009, C.auris has spread rapidly across continents and is now classified by both the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) as a critical-priority pathogen. This review summarizes current knowledge on the origin, taxonomy, microbiology, and virulence mechanisms of C.auris, emphasizing its thermotolerance, osmotolerance, and biofilm-forming capacity on biotic and abiotic surfaces, as well as aspects related to its antifungal drug resistance and management. These features, together with its genomic plasticity, contribute to persistence, transmission, and drug resistance. Emerging evidence also supports a potential link between climate change and C. auris evolution, highlighting environmental adaptation as a driver of pathogenicity. Combating C. auris will require multidisciplinary efforts to mitigate its expanding global impact.